Randomized Study of Extended Treatment With Firibastat in Treatment-Resistant Hypertension (REFRESH)

NCT04857840 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

419

Enrollment

INDUSTRY

Sponsor class

Stopped No Efficacy demonstrated inn the QGC001-3QG1 study

Conditions

Hypertension (HTN)

Interventions

DRUG: Firibastat (QGC001) Period 1

Sponsor

Quantum Genomics SA

Collaborators

[object Object]